Report Details

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Therapy Viral Vector and Plasmid DNA Market Size Comparison by Region (M USD)
Table 5. Global Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gene Therapy Viral Vector and Plasmid DNA Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gene Therapy Viral Vector and Plasmid DNA Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Viral Vector and Plasmid DNA as of 2022)
Table 10. Global Market Gene Therapy Viral Vector and Plasmid DNA Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gene Therapy Viral Vector and Plasmid DNA Sales Sites and Area Served
Table 12. Manufacturers Gene Therapy Viral Vector and Plasmid DNA Product Type
Table 13. Global Gene Therapy Viral Vector and Plasmid DNA Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gene Therapy Viral Vector and Plasmid DNA
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy Viral Vector and Plasmid DNA Market Challenges
Table 22. Global Gene Therapy Viral Vector and Plasmid DNA Sales by Type (K Units)
Table 23. Global Gene Therapy Viral Vector and Plasmid DNA Market Size by Type (M USD)
Table 24. Global Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) by Type (2019-2024)
Table 25. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Type (2019-2024)
Table 26. Global Gene Therapy Viral Vector and Plasmid DNA Market Size (M USD) by Type (2019-2024)
Table 27. Global Gene Therapy Viral Vector and Plasmid DNA Market Size Share by Type (2019-2024)
Table 28. Global Gene Therapy Viral Vector and Plasmid DNA Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) by Application
Table 30. Global Gene Therapy Viral Vector and Plasmid DNA Market Size by Application
Table 31. Global Gene Therapy Viral Vector and Plasmid DNA Sales by Application (2019-2024) & (K Units)
Table 32. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Application (2019-2024)
Table 33. Global Gene Therapy Viral Vector and Plasmid DNA Sales by Application (2019-2024) & (M USD)
Table 34. Global Gene Therapy Viral Vector and Plasmid DNA Market Share by Application (2019-2024)
Table 35. Global Gene Therapy Viral Vector and Plasmid DNA Sales Growth Rate by Application (2019-2024)
Table 36. Global Gene Therapy Viral Vector and Plasmid DNA Sales by Region (2019-2024) & (K Units)
Table 37. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Region (2019-2024)
Table 38. North America Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Sales by Region (2019-2024) & (K Units)
Table 41. South America Gene Therapy Viral Vector and Plasmid DNA Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Sales by Region (2019-2024) & (K Units)
Table 43. Lonza Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 44. Lonza Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 45. Lonza Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Lonza Business Overview
Table 47. Lonza Gene Therapy Viral Vector and Plasmid DNA SWOT Analysis
Table 48. Lonza Recent Developments
Table 49. Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 50. Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 51. Merck KGaA Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merck KGaA Business Overview
Table 53. Merck KGaA Gene Therapy Viral Vector and Plasmid DNA SWOT Analysis
Table 54. Merck KGaA Recent Developments
Table 55. Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 56. Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 57. Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Thermo Fisher Scientific Gene Therapy Viral Vector and Plasmid DNA SWOT Analysis
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Recent Developments
Table 61. Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 62. Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 63. Charles River Laboratories Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Charles River Laboratories Business Overview
Table 65. Charles River Laboratories Recent Developments
Table 66. Catalent Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 67. Catalent Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 68. Catalent Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Catalent Business Overview
Table 70. Catalent Recent Developments
Table 71. WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 72. WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 73. WuXi AppTec Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. WuXi AppTec Business Overview
Table 75. WuXi AppTec Recent Developments
Table 76. FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 77. FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 78. FUJIFILM Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. FUJIFILM Business Overview
Table 80. FUJIFILM Recent Developments
Table 81. GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 82. GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 83. GenScript Biotech Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. GenScript Biotech Business Overview
Table 85. GenScript Biotech Recent Developments
Table 86. Takara Bio Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 87. Takara Bio Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 88. Takara Bio Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Takara Bio Business Overview
Table 90. Takara Bio Recent Developments
Table 91. Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 92. Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 93. Oxford Biomedica Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Oxford Biomedica Business Overview
Table 95. Oxford Biomedica Recent Developments
Table 96. Novartis Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 97. Novartis Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 98. Novartis Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Novartis Business Overview
Table 100. Novartis Recent Developments
Table 101. Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 102. Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 103. Precision Biosciences Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Precision Biosciences Business Overview
Table 105. Precision Biosciences Recent Developments
Table 106. Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 107. Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 108. Bluebird Bio Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Bluebird Bio Business Overview
Table 110. Bluebird Bio Recent Developments
Table 111. Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 112. Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 113. Sartorius AG Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Sartorius AG Business Overview
Table 115. Sartorius AG Recent Developments
Table 116. Danaher Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 117. Danaher Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 118. Danaher Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Danaher Business Overview
Table 120. Danaher Recent Developments
Table 121. SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 122. SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 123. SIRON Biotech Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. SIRON Biotech Business Overview
Table 125. SIRON Biotech Recent Developments
Table 126. VGXI Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 127. VGXI Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 128. VGXI Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. VGXI Business Overview
Table 130. VGXI Recent Developments
Table 131. Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 132. Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 133. Waisman Biomanufacturing Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Waisman Biomanufacturing Business Overview
Table 135. Waisman Biomanufacturing Recent Developments
Table 136. Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 137. Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 138. Kaneka Eurogentec Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Kaneka Eurogentec Business Overview
Table 140. Kaneka Eurogentec Recent Developments
Table 141. PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 142. PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 143. PlasmidFactory Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. PlasmidFactory Business Overview
Table 145. PlasmidFactory Recent Developments
Table 146. ATUM Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 147. ATUM Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 148. ATUM Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. ATUM Business Overview
Table 150. ATUM Recent Developments
Table 151. Addgene Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 152. Addgene Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 153. Addgene Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Addgene Business Overview
Table 155. Addgene Recent Developments
Table 156. Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 157. Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 158. Cell and Gene Therapy Catapult Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Cell and Gene Therapy Catapult Business Overview
Table 160. Cell and Gene Therapy Catapult Recent Developments
Table 161. Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 162. Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 163. Batavia biosciences Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Batavia biosciences Business Overview
Table 165. Batavia biosciences Recent Developments
Table 166. Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Basic Information
Table 167. Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Product Overview
Table 168. Altogen Biosystems Gene Therapy Viral Vector and Plasmid DNA Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Altogen Biosystems Business Overview
Table 170. Altogen Biosystems Recent Developments
Table 171. Global Gene Therapy Viral Vector and Plasmid DNA Sales Forecast by Region (2025-2030) & (K Units)
Table 172. Global Gene Therapy Viral Vector and Plasmid DNA Market Size Forecast by Region (2025-2030) & (M USD)
Table 173. North America Gene Therapy Viral Vector and Plasmid DNA Sales Forecast by Country (2025-2030) & (K Units)
Table 174. North America Gene Therapy Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 175. Europe Gene Therapy Viral Vector and Plasmid DNA Sales Forecast by Country (2025-2030) & (K Units)
Table 176. Europe Gene Therapy Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 177. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Sales Forecast by Region (2025-2030) & (K Units)
Table 178. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Market Size Forecast by Region (2025-2030) & (M USD)
Table 179. South America Gene Therapy Viral Vector and Plasmid DNA Sales Forecast by Country (2025-2030) & (K Units)
Table 180. South America Gene Therapy Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 181. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Consumption Forecast by Country (2025-2030) & (Units)
Table 182. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Market Size Forecast by Country (2025-2030) & (M USD)
Table 183. Global Gene Therapy Viral Vector and Plasmid DNA Sales Forecast by Type (2025-2030) & (K Units)
Table 184. Global Gene Therapy Viral Vector and Plasmid DNA Market Size Forecast by Type (2025-2030) & (M USD)
Table 185. Global Gene Therapy Viral Vector and Plasmid DNA Price Forecast by Type (2025-2030) & (USD/Unit)
Table 186. Global Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) Forecast by Application (2025-2030)
Table 187. Global Gene Therapy Viral Vector and Plasmid DNA Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Gene Therapy Viral Vector and Plasmid DNA
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy Viral Vector and Plasmid DNA Market Size (M USD), 2019-2030
Figure 5. Global Gene Therapy Viral Vector and Plasmid DNA Market Size (M USD) (2019-2030)
Figure 6. Global Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy Viral Vector and Plasmid DNA Market Size by Country (M USD)
Figure 11. Gene Therapy Viral Vector and Plasmid DNA Sales Share by Manufacturers in 2023
Figure 12. Global Gene Therapy Viral Vector and Plasmid DNA Revenue Share by Manufacturers in 2023
Figure 13. Gene Therapy Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gene Therapy Viral Vector and Plasmid DNA Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gene Therapy Viral Vector and Plasmid DNA Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gene Therapy Viral Vector and Plasmid DNA Market Share by Type
Figure 18. Sales Market Share of Gene Therapy Viral Vector and Plasmid DNA by Type (2019-2024)
Figure 19. Sales Market Share of Gene Therapy Viral Vector and Plasmid DNA by Type in 2023
Figure 20. Market Size Share of Gene Therapy Viral Vector and Plasmid DNA by Type (2019-2024)
Figure 21. Market Size Market Share of Gene Therapy Viral Vector and Plasmid DNA by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gene Therapy Viral Vector and Plasmid DNA Market Share by Application
Figure 24. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Application (2019-2024)
Figure 25. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Application in 2023
Figure 26. Global Gene Therapy Viral Vector and Plasmid DNA Market Share by Application (2019-2024)
Figure 27. Global Gene Therapy Viral Vector and Plasmid DNA Market Share by Application in 2023
Figure 28. Global Gene Therapy Viral Vector and Plasmid DNA Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Region (2019-2024)
Figure 30. North America Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Country in 2023
Figure 32. U.S. Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gene Therapy Viral Vector and Plasmid DNA Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gene Therapy Viral Vector and Plasmid DNA Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Country in 2023
Figure 37. Germany Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Region in 2023
Figure 44. China Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (K Units)
Figure 50. South America Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Country in 2023
Figure 51. Brazil Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gene Therapy Viral Vector and Plasmid DNA Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gene Therapy Viral Vector and Plasmid DNA Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gene Therapy Viral Vector and Plasmid DNA Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gene Therapy Viral Vector and Plasmid DNA Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gene Therapy Viral Vector and Plasmid DNA Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gene Therapy Viral Vector and Plasmid DNA Market Share Forecast by Type (2025-2030)
Figure 65. Global Gene Therapy Viral Vector and Plasmid DNA Sales Forecast by Application (2025-2030)
Figure 66. Global Gene Therapy Viral Vector and Plasmid DNA Market Share Forecast by Application (2025-2030)